The 2016 Alzheimer’s Association International Conference (AAIC)

An IOA Guest Blog by Rebecca Cweibel, Research Coordinator, AD Genetics, Wang Lab, University of Pennsylvania

The 2016 Alzheimer’s Association International Conference (AAIC) was held last month in Toronto, Ontario, Canada. The annual conference gathers thousands of physicians, scholars, and advocates who work on Alzheimer’s disease (AD) and related dementias (ADRD). The event had such a considerable local impact that banners for the conference appeared throughout Toronto Pearson International Airport, the downtown core, and the event even made the front page of the Toronto Star local newspaper.

The weeklong session hosted plenary sessions, focused research sessions featuring several speakers on similar topics, poster sessions, and many other formats fostering communication around AD. University of Pennsylvania researchers, including members of IOA collaborator Li-San Wang, PhD’s lab presented during the meeting’s poster sessions.

The NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) is the Data Coordinating Center for the Alzheimer’s Disease Sequencing Project (ADSP), an effort designed to meet the research goals outlined in the National Plan to Address Alzheimer’s Disease, and developed under the National Alzheimer’s Project Act.


Amanda Kuzma presenting her poster on behalf of the ADSP Data Flow Work Group.

The Alzheimer’s Association works to address AD through research grants; publishing Alzheimer’s and Dementia, a peer-reviewed scientific journal; connecting patients and families of those with AD and other dementias, online and in-person; and lobbying congress to continue funding AD.

Given the depth of the Alzheimer’s Association’s reach, AAIC is such a large gathering of AD scholars physicians, and advocates that it is impossible to experience everything the conference has to offer. The Alzheimer’s Association keeps a log of media coverage on the conference, featuring over 70 articles.

Next year, AAIC will take place July 16-20, 2017, in London.



Penn Alzheimer’s Disease Core Center (ADCC) Receives $8.8 Million Renewal

It was announced today that the University of Pennsylvania’s Alzheimer’s Disease Core Center (ADCC) has officially been awarded a five year, $8.8 million renewal from the National Institute on Aging (NIA) at the National Institutes of Health (NIH) to continue investigating the progression, diagnostics, treatments, and strategies of Alzheimer’s disease and related dementias.

“We are hopeful our support for the Penn ADC research program will lead to novel findings on the basic mechanisms involved in these diseases, and innovative new programs aimed at improving the lives of those living with dementia and their caregivers,” explained Nina Silverberg, PhD, an Alzheimer’s Disease Centers program director at NIA, in the Penn Medicine announcement.

The Penn ADCC has a history of groundbreaking discoveries, including identifying the protein tau as the building block of neurofibrillary tangles, as well as the role of alpha-synuclein in forming the Lewy bodies that are found in Parkinson’s disease, Parkinson’s disease dementia, Lewy body dementia, and 50% of Alzheimer’s cases.

Learn more about the Penn ADCC in the video* below:

Read the full Penn Medicine Announcement here.

Visit the Penn ADCC website here.

* Steven Arnold, MD is no longer at the University of Pennsylvania. David A. Wolk, MD is now the Clinical Core leader for the Penn Alzheimer’s Disease Core Center (ADCC).